Landoulsi, Zied, Sreelatha, Ashwin Ashok Kumar, Kuznetsov, Nicole, Schulte, Claudia, Bobbili, Dheeraj Reddy, Williams, Nigel ORCID: https://orcid.org/0000-0003-1177-6931 and Escott-Price, Valentina ORCID: https://orcid.org/0000-0003-1784-5483
2026.
Genome-wide association study of copy number variations in Parkinson’s disease.
npj Parkinson's Disease
12
, 160.
10.1038/s41531-025-01245-z
|
|
PDF
- Published Version
Available under License Creative Commons Attribution. Download (1MB) |
Abstract
We investigated the role of copy number variations (CNVs) in Parkinson’s disease (PD) using genotyping data from 10,815 patients (2731 early-onset PD, EOPD) and 8901 controls from the COURAGE-PD consortium. CNVs were analyzed using a sliding window genome-wide association and burden approach. No genome-wide significant CNVs were detected in the overall cohort, but a robust deletion spanning exons 2–6 of PRKN was identified in EOPD cases, validated by MLPA, and replicated in the GP2 dataset (23,089 cases, 18,824 controls). CNV burden was significantly enriched in PD-related genes, primarily driven by PRKN, with the strongest effect observed in EOPD. PRKN CNV carriers showed earlier age at onset, confirmed by survival analysis. No association was observed for genome-wide or large CNV burden. Our findings reinforce the pivotal role of PRKN deletions in early-onset PD and highlight the need for high-resolution CNV analysis in large cohorts to uncover additional rare contributors to PD risk.
| Item Type: | Article |
|---|---|
| Date Type: | Publication |
| Status: | Published |
| Schools: | Schools > Medicine |
| Additional Information: | Full author list available at DOI |
| Publisher: | Nature Research |
| Date of First Compliant Deposit: | 20 July 2026 |
| Date of Acceptance: | 16 December 2025 |
| Last Modified: | 20 Jul 2026 13:34 |
| URI: | https://orca.cardiff.ac.uk/id/eprint/188341 |
Actions (repository staff only)
![]() |
Edit Item |





Dimensions
Dimensions